Drug Database · Clinicians

Metronidazole + Nystatin

Brands (1) FlagystatinShow all

Antiprotozoal (nitroimidazole derivative)/ antifungal PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group ( B. fragilis , B. distasonis , B. ovatus , B. thetaiotaomicron… US FDA label

    Kidney dosing: Metronidazole (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl 30–59 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl 15–29 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl <15 mL/min (not on dialysis)
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label). In end-stage kidney disease, peak levels of hydroxy-metronidazole were 2 times and of metronidazole acetate 5 times normal (label PK). Because metabolites accumulate in end-stage kidney disease, monitoring for metronidazole-associated adverse events is recommended (label).
    Hemodialysis (intermittent)
    Hemodialysis (4 to 8 hours) removes 40% to 65% of a dose. If dosing cannot be separated from the session, consider a supplemental dose after hemodialysis (label).
    Peritoneal dialysis
    No dose change on CAPD; a 7.5-hour peritoneal dialysis removed about 10% of a dose (label).
    CRRT
    Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
    • Dialyzable? Hemodialysis: yes (40% to 65% of a dose per 4- to 8-hour session, by membrane and duration). Peritoneal dialysis: little (about 10%) (label). Under 20% protein bound.
    • Monitoring Neurologic symptoms (encephalopathy, cerebellar signs, seizures, peripheral or optic neuropathy, aseptic meningitis); liver function in hepatic impairment; INR with warfarin; lithium and creatinine with lithium (label).

    From the Metronidazole monograph (renalcarematters.com, reviewed).

  • Use: INDICATIONS AND USAGE Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans . US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Metronidazole + Nystatin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Metronidazole + Nystatin
Package insert
FlagystatinMetronidazole + Nystatin
500mg/ 100,000 I.U. Vaginal SuppositoryWhite opaque PVC/PE Rotoplast pack by 5's Box of 10 vaginal suppositories
Rx
PT Aventis PharmaIndonesia
Importer: SANOFI-AVENTIS PHILIPPINES INC
DRP-088
Nov 22, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .